These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31138756)

  • 1. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
    Wang W
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
    Shah BK; Khanal A
    Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL; Jain KS; Morris LG
    Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
    Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
    JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
    Goldfarb M; Rosenberg AS; Li Q; Keegan THM
    Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk and prognosis of secondary primary malignancy in lung cancer: a population-based study.
    Hong J; Wei R; Nie C; Leonteva A; Han X; Du X; Wang J; Zhu L; Tian W; Zhou H
    Future Oncol; 2021 Nov; 17(33):4497-4509. PubMed ID: 34402680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study.
    Wang J; Du Y; Kang Y
    Int J Gynaecol Obstet; 2024 Jun; 165(3):1229-1236. PubMed ID: 38205842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis.
    Jiang S; Zhen H; Jiang H
    Curr Probl Cancer; 2020 Feb; 44(1):100502. PubMed ID: 31537411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis.
    Jiang S; Jiang H; Sun L; Luo Z
    Curr Probl Cancer; 2021 Apr; 45(2):100641. PubMed ID: 32928566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of second primary malignancy after breast cancer and related risk factors-Is breast-conserving surgery safe? A nested case-control study.
    Li Z; Wang K; Shi Y; Zhang X; Wen J
    Int J Cancer; 2020 Jan; 146(2):352-362. PubMed ID: 30861567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment.
    Brown AL; Arroyo VM; Agrusa JE; Scheurer ME; Gramatges MM; Lupo PJ
    Cancer; 2019 Oct; 125(20):3623-3630. PubMed ID: 31251393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
    Khanal A; Budhathoki N; Singh VP; Shah BK
    Anticancer Res; 2017 Apr; 37(4):2033-2036. PubMed ID: 28373478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
    Jia H; Li Q; Yuan J; Sun X; Wu Z
    Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
    Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second primary malignancy in patients with cholangiocarcinoma: a population-based study.
    Zhuang L; Yan X; Meng Z
    Cancer Manag Res; 2019; 11():1969-1983. PubMed ID: 30881122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study.
    Yang Y; Yang Y; Yan S
    Curr Probl Cancer; 2021 Dec; 45(6):100735. PubMed ID: 33867153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.